3648 results for «2594»
3648 results
Aneurysms and fistulas: contemporary approaches
21 May 2026 – From EuroPCR 2026
Focus on contemporary approaches to coronary aneurysms and fistulas, presenting complex interventional techniques and case-based strategies to overcome anatomical challenges and ensure effective treatment.
Refining the gold standard: what is new in DES
21 May 2026 – From EuroPCR 2026
This session explores recent advancements in drug-eluting stent (DES) technology, featuring global real-world evidence on short dual antiplatelet therapy (DAPT) with polymer-free DES, angiographic outcomes from pooled TARGET trials, and real-world registry data on various DES platforms. It also presents post-marketing surveillance results and systematic reviews...
How to achieve coronary patency during TAVI
21 May 2026 – From EuroPCR 2026
This session addresses techniques to achieve coronary artery patency during transcatheter aortic valve implantation (TAVI), highlighting advanced procedural approaches and management of high-risk anatomical scenarios.
Innovations in TAVI: TAVI 2.0
21 May 2026 – From EuroPCR 2026
This session presents cutting-edge advancements in transcatheter aortic valve implantation (TAVI), highlighting the TAVI 2.0 era. It encompasses innovative techniques such as percutaneous and non-fluoroscopic TAVR guided by transthoracic echocardiography (TTE), novel alternative access via the left subscapular approach, and patient-tailored commissural alignment assessed through CT...
Sealing the deal: catheter based solutions for aortic disease
21 May 2026 – From EuroPCR 2026
Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.
Various NSTEMI cases
21 May 2026 – From EuroPCR 2026
This session presents diverse NSTEMI case studies addressing complex diagnostic and interventional challenges, including coronary dissections, intramural hematomas, ischemic complications, and functional lesion assessment.
NSTEMI: when everything does not go as planned
21 May 2026 – From EuroPCR 2026
This session presents complex cases of NSTEMI where unexpected challenges arise during intervention. It provides a comprehensive review of complication management strategies, including coronary perforation techniques. Through detailed case analyses from diverse centers, attendees gain practical insights into troubleshooting and treatment adaptations essential for managing difficult...
Imaging evaluation in structural heart interventions
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive evaluation of imaging techniques applied in structural heart interventions. It covers innovative studies including the impact of Dapagliflozin on multivalvular disease post-TAVI, advanced fusion methods combining CT and echocardiography to assess aortic stenosis severity, and the clinical relevance of the fibrocalcific...
New platforms for coronary lesions treatment
21 May 2026 – From EuroPCR 2026
Delve into the latest developments in coronary lesion treatment platforms through this session, highlighting real-world performance data of novel drug-eluting stents like Eternia and Evermine 50. It also presents preclinical insights on biomimetic CD31-coated stents, long-term outcomes of the Fantom BRS platform, and innovative randomized trials...
Risk stratification and reperfusion strategies for acute and subacute pulmonary embolism
21 May 2026 – From EuroPCR 2026
Focus on risk stratification and reperfusion strategies for acute and subacute pulmonary embolism through this session. It discusses the impact of elective endovascular therapies in intermediate-high risk patients, intraprocedural complications, and early mortality associated with catheter interventions. Additionally, it reviews real-world outcomes of catheter-directed therapy, national...
Percutaneous management of mitral and aortic valve disease
21 May 2026 – From EuroPCR 2026
Delve into the percutaneous management of mitral and aortic valve disease through detailed procedural demonstrations. This session covers valve-in-valve procedures, navigation of potential complications in valve-in-valve TAVI, and mitral valve edge-to-edge repair techniques, supported by real-world case discussions and key learnings.
Complex multivessel disease: from calcium to physiology - Case-based decisions
21 May 2026 – From EuroPCR 2026
Focus on complex multivessel coronary artery disease management with an emphasis on severely calcified lesions and the integration of intracoronary imaging and physiology. This session prepares clinicians to anticipate and manage complications during PCI, enhancing competence in treating challenging coronary anatomies through case-based decision-making.
LAA closure and pulmonary embolism hotline
22 May 2026 – From EuroPCR 2026
Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.
Insight from new evidence for complex PCI: value of imaging (CHIP IVUS) and left ventricular support (CHIP BCIS 3)
21 May 2026 – From EuroPCR 2026
This session reviews the impact of recent evidence on complex PCI, highlighting the value of intracoronary imaging (CHIP IVUS trial) and left ventricular assist devices (CHIP BCIS 3 trial). Through case discussions, participants reflect on how these innovations influence daily clinical practice and enhance procedural planning...
Taking on the tough stuff: TAVI in complex anatomies
21 May 2026 – From EuroPCR 2026
Focused on the challenges of transcatheter aortic valve implantation (TAVI) in complex anatomies, this session addresses optimal strategies for treating bicuspid aortic valve stenosis, managing small annuli and low coronary ostia, and approaches to degenerated surgical valves including bioprosthetic fracture techniques. Case-based discussions elucidate practical solutions...
Spotlight - TAVI durability: contemporary evidence and future directions
21 May 2026 – From EuroPCR 2026
Focusing on TAVI durability, this session reviews recent clinical evidence from randomized trials and large registries, examining procedural and device-related factors influencing long-term valve performance. It also discusses challenges in follow-up and implications for future trial designs and device monitoring.
Multivessel complications: what can go wrong
21 May 2026 – From EuroPCR 2026
This session highlights complications encountered in multivessel coronary interventions, presenting complex cases such as lost stents, coronary perforations, shaft fractures, early subacute stent thrombosis, and rare triple vessel thrombosis. It emphasizes practical management strategies for these challenging scenarios in contemporary interventional cardiology.
INOCA/ANOCA: view insights from clinical practice
19 May 2026 – From EuroPCR 2026
This session provides in-depth clinical insights into INOCA and ANOCA by exploring innovative invasive assessments of coronary microcirculation and vasoreactivity, with a focus on diabetic populations and sex differences. It reviews distinct IMR-based phenotypes differentiating flow versus pressure-driven microvascular dysfunction, and the role of invasive hemodynamics...
New data on intracoronary imaging-guided interventions
21 May 2026 – From EuroPCR 2026
This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...
News from drug-eluting therapies in 2026
19 May 2026 – From EuroPCR 2026
This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.